{"id":128322,"date":"2024-07-11T13:14:00","date_gmt":"2024-07-11T07:44:00","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=128322"},"modified":"2024-07-11T13:14:03","modified_gmt":"2024-07-11T07:44:03","slug":"2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/","title":{"rendered":"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1158787856\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of the leading API manufacturer have fallen up to 4 percent after the board of a parent company plans to offload 7.84 percent in the company via an offer for sale.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-658517061\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLS\/standalone\" target=\"_blank\" rel=\"noreferrer noopener\">Glenmark Life Sciences Ltd<\/a><\/strong> were trading at Rs 848.30 per share, decreasing around 3.49 percent as compared to the previous closing price of Rs 878.95 apiece. The market capitalization of Rs 10,393.98 crore. <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLENMARK\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Glenmark Pharmaceuticals Ltd<\/a><\/strong> trading at Rs 1,375 apiece has fallen 2% from the previous closing price.\u00a0<\/p><h3 class=\"wp-block-heading\"><strong>Matter Explanation:-&nbsp;<\/strong><\/h3><p>Today the company shares have seen a bearish movement after Glenmark Pharma&#8217;s board of directors approved the company&#8217;s plans to offload a 7.84 percent stake in Glenmark Life Sciences through an offer for sale.\u00a0<\/p><h3 class=\"wp-block-heading\"><strong>Also read<\/strong><\/h3><figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"IEvKfTw4Jd\"><a href=\"https:\/\/tradebrains.in\/features\/railway-stock-jumps-5-after-receiving-an-order-worth-138-45-cr-from-central-railway\/\">Railway stock jumps 5% after receiving an order worth \u20b9 138.45 Cr from Central Railway\u00a0<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Railway stock jumps 5% after receiving an order worth \u20b9 138.45 Cr from Central Railway\u00a0&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/railway-stock-jumps-5-after-receiving-an-order-worth-138-45-cr-from-central-railway\/embed\/#?secret=5Z6yola4vY#?secret=IEvKfTw4Jd\" data-secret=\"IEvKfTw4Jd\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><p>With this OFS, Glenmark Pharma will totally depart Glenmark Life Sciences. The OFS floor price is determined at Rs 810 per share, reflecting a 7.5% discount from Glenmark Life Sciences&#8217; last closing price. The OFS&#8217;s broker will be Kotak Securities Limited.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-740135140\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h3 class=\"wp-block-heading\"><strong>Financial Condition:-&nbsp;<\/strong><\/h3><p>Examine the company&#8217;s financial performance, revenue plummeted by 35 percent from Rs 621 crore in Q4FY23 to Rs 537 crore in Q4FY24. During the same period, net profit shrunk significantly by 33 percent, from Rs 146 crore to Rs 98 crore.&nbsp;<\/p><h3 class=\"wp-block-heading\"><strong>Previous Acquisition &amp; portfolio:-&nbsp;<\/strong><\/h3><p>In March of this year, Indian conglomerate Nirma completed the acquisition of a 75% share in Glenmark Life Sciences. Under the terms of the share purchase deal, Nirma bought 9.19 crore equity shares, establishing itself as GLS&#8217;s promoter.&nbsp;<\/p><p>GLS has a portfolio of 146 compounds, GLS serves chronic therapeutic areas such as cardiovascular illness, central nervous system disease, pain management, and diabetes. Its purchase has greatly increased Nirma&#8217;s footprint in the pharmaceuticals and life sciences industry.&nbsp;<\/p><h3 class=\"wp-block-heading\"><strong>Company Snapshot:-&nbsp;<\/strong><\/h3><p>Glenmark Life Sciences Limited is an India-based firm that focuses on developing, manufacturing, and selling active medicinal ingredients. The Company&#8217;s product portfolio includes treatments for cardiovascular (CVS) illness and other therapeutic areas.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by:- Abhishek Singh<\/strong><\/p><\/blockquote><h3 class=\"wp-block-heading\"><strong>Disclaimer<\/strong><\/h3><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2358882230\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of the leading API manufacturer have fallen up to 4 percent after the board of a parent company plans to offload 7.84 percent in the company via an offer for sale.&nbsp; The shares of Glenmark Life Sciences Ltd were trading at Rs 848.30 per share, decreasing around 3.49 percent as compared to the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[12368,1487,20404,948,936],"class_list":["post-128322","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-glenmark-pharmaceuticals-latest-news","tag-glenmark-pharmaceuticals-share-price","tag-glenmark-pharmaceuticals-stake-sell","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0 - Trade Brains Features<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0\" \/>\n<meta property=\"og:description\" content=\"The shares of the leading API manufacturer have fallen up to 4 percent after the board of a parent company plans to offload 7.84 percent in the company via an offer for sale.&nbsp; The shares of Glenmark Life Sciences Ltd were trading at Rs 848.30 per share, decreasing around 3.49 percent as compared to the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-11T07:44:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-11T07:44:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/\",\"url\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/\",\"name\":\"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-07-11T07:44:00+00:00\",\"dateModified\":\"2024-07-11T07:44:03+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0 - Trade Brains Features","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/","og_locale":"en_US","og_type":"article","og_title":"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0","og_description":"The shares of the leading API manufacturer have fallen up to 4 percent after the board of a parent company plans to offload 7.84 percent in the company via an offer for sale.&nbsp; The shares of Glenmark Life Sciences Ltd were trading at Rs 848.30 per share, decreasing around 3.49 percent as compared to the [&hellip;]","og_url":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-07-11T07:44:00+00:00","article_modified_time":"2024-07-11T07:44:03+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/","url":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/","name":"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-07-11T07:44:00+00:00","dateModified":"2024-07-11T07:44:03+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/2-pharma-stocks-fall-4-after-parent-company-plans-to-offload-7-84-stake-in-the-company-via-ofs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"2 Pharma stocks fall 4% after parent company plans to offload 7.84% stake in the company via OFS\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/128322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=128322"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/128322\/revisions"}],"predecessor-version":[{"id":128324,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/128322\/revisions\/128324"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=128322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=128322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=128322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}